RemeGen Co., Ltd.
REGMF
$1.50
-$0.54-26.47%
09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
---|---|---|---|---|---|
Revenue | 65.54M | 56.51M | 46.03M | 42.47M | 48.38M |
Total Other Revenue | -293.40K | 290.10K | -- | 945.00K | -463.20K |
Total Revenue | 65.25M | 56.80M | 46.03M | 43.42M | 47.92M |
Cost of Revenue | 10.34M | 13.31M | 10.36M | 11.01M | 10.18M |
Gross Profit | 54.91M | 43.49M | 35.67M | 32.41M | 37.73M |
SG&A Expenses | 45.43M | 37.48M | 37.11M | 41.33M | 37.90M |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | 31.70K | -1.06M | -921.70K | -3.30M | -470.10K |
Total Operating Expenses | 104.30M | 115.33M | 92.68M | 111.13M | 91.45M |
Operating Income | -39.05M | -58.53M | -46.65M | -67.72M | -43.54M |
Income Before Tax | -40.64M | -59.59M | -48.60M | -66.57M | -45.18M |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | -40.64M | -59.59M | -48.60M | -66.57M | -45.18M |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -40.64M | -59.59M | -48.60M | -66.57M | -45.18M |
EBIT | -39.05M | -58.53M | -46.65M | -67.72M | -43.54M |
EBITDA | -33.04M | -50.96M | -40.66M | -61.76M | -39.26M |
EPS Basic | -0.08 | -0.11 | -0.09 | -0.12 | -0.08 |
Normalized Basic EPS | -0.05 | -0.07 | -0.06 | -0.08 | -0.05 |
EPS Diluted | -0.08 | -0.11 | -0.09 | -0.12 | -0.08 |
Normalized Diluted EPS | -0.05 | -0.07 | -0.06 | -0.08 | -0.05 |
Average Basic Shares Outstanding | 538.72M | 539.69M | 536.80M | 540.18M | 536.63M |
Average Diluted Shares Outstanding | 538.72M | 539.69M | 536.80M | 540.18M | 536.63M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -8.05% | -4.82% | -2.58% | -0.91% | -3.37% |